Last update 01 Mar 2025

MTI-201

Overview

Basic Info

Drug Type
Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals
Synonyms
Actinium-225-DOTA-Ahx-MC1RL, DOTA-Ahx-MC1RL-[225Ac], 225AC-DOTA-AHX-MC1RL
+ [4]
Target
HER2
Mechanism
HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists)
Therapeutic Areas
NeoplasmsEye DiseasesSkin and Musculoskeletal Diseases+ [1]
Active Indication
Uveal Melanoma
Inactive Indication-
Originator Organization
Modulation Therapeutics, Inc.Modulation Therapeutics, Inc.
Active Organization
Modulation Therapeutics, Inc.Modulation Therapeutics, Inc.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with MTI-201
NCT05496686
/ RecruitingPhase 1
First in Human Phase I Study of 225Actinium-MTI-201 (225Ac-MTI-201) in Metastatic Uveal Melanoma
100 Clinical Results associated with MTI-201
Login to view more data
100 Translational Medicine associated with MTI-201
Login to view more data
100 Patents (Medical) associated with MTI-201
Login to view more data
100 Deals associated with MTI-201
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Uveal MelanomaPhase 1
US
Modulation Therapeutics, Inc.Modulation Therapeutics, Inc.
21 Jul 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free